series-a
Stage
2
Investors
About
Eyenuk develops FDA-cleared autonomous AI software for the detection of diabetic retinopathy and other retinal diseases through non-invasive retinal imaging, enabling rapid, specialist-free screening at the point of care.
Explore Eyenuk's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.